Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 October 2019 | Story Ruan Bruwer | Photo Varsity Sports
Lefebere and Khanyisa
Lefébre Rademan (left) and Khanyisa Chawane before the start of the Varsity Netball clash. Rademan was named the Player of the Tournament, a reward Chawane received last year.

For the sixth time in the seven years of the competition, the best player in the Varsity Netball tournament hails from the University of the Free State (UFS).

Lefébre Rademan, captain of the Kovsie netball team who ended third in Varsity Netball, was named as the Player of the Tournament and the Players’ Player of the Tournament on Monday night (7 October). Previous UFS recipients of the award are Ané Bester (2013), Karla Pretorius (in 2014 and 2015), Khomotso Mamburu (2016), and Khanyisa Chawane (2018).

Rademan shot 176 goals from 214 attempts for a goal average of 82%. In both the Premier League and National Championship, she received the prize for the best shooter this year.

The news comes shortly after the announcement that a UFS teammate has secured a contract to play overseas next year. Khanyisa Chawane, who impressed immensely as a member of the Proteas at this year’s World Cup, will represent Bath in Europe’s Superleague. The 23-year-old Chawane also received an offer to play in the Australian league, but the one in England suited her better.

She will return to Bloemfontein midway through the year and will still be available for the Kovsie netball team, as she will continue her studies. The talented mid-courter follows in the footsteps of Pretorius, who also spent a season with Bath in 2016.

“I am really thrilled to have signed with Bath. There is no doubt that I’m going to come out a better player; I’m grateful to have been scouted and given this opportunity to play for such a big team. It still brings tears to my eyes when I think about it.”

“My goal has always been to play abroad and to challenge myself. I always strive to better myself and give my best on and off court,” Chawane said about the opportunity next year.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept